
| SKU | A01505-3 |
|---|---|
| Application | Immunofluorescence |
| Sample | PC-3 xenograft mouse tissue |
| Sample Processing Description | (1) PC-3 cells were implanted in nude mice to form tumors as the control group; (2) tumor-bearing mice were treated with the drug docetaxel. |
| Other Reagents | Goat serum, DAPI, Anti-fade mounting medium |
| Primary Antibody | Prostate Specific Antigen/KLK3 Antibody Picoband® |
| Primary Incubation | 1:500, overnight at 4 ℃ |
| Secondary Antibody | DyLight 594–conjugated Goat Anti-Rabbit IgG (H+L)) |
| Secondary Incubation | 1:500, 45 min at 37℃ |
| Detection | Imaging system:Leica DM2500 |
| Results Summary | PSA, or prostate-specific antigen, is a multifaceted tumor marker that can promote the proliferation and migration of prostate cancer cells, driving tumor growth. After treatment with docetaxel, its secretion is expected to decrease, which is confirmed by the experimental results showing markedly reduced PSA expression in the xenograft tumor cells following treatment. |










